Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation.
Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H, Joseph D, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, Francis L, Kramar A, D'Este C, Bill D. Christie D, et al. Among authors: mameghan h. Radiother Oncol. 2005 Nov;77(2):117-25. doi: 10.1016/j.radonc.2005.10.005. Epub 2005 Nov 4. Radiother Oncol. 2005. PMID: 16271786 Clinical Trial.
Acceptability of short term neo-adjuvant androgen deprivation in patients with locally advanced prostate cancer.
Lamb DS, Denham JW, Mameghan H, Joseph D, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Kovacev O, Robertson R, Francis L, Christie D, Spry NA, Tai KH, Wynne C, Duchesne G. Lamb DS, et al. Among authors: mameghan h. Radiother Oncol. 2003 Sep;68(3):255-67. doi: 10.1016/s0167-8140(03)00193-2. Radiother Oncol. 2003. PMID: 13129633 Clinical Trial.
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial.
Denham JW, Steigler A, Lamb DS, Joseph D, Mameghan H, Turner S, Matthews J, Franklin I, Atkinson C, North J, Poulsen M, Christie D, Spry NA, Tai KH, Wynne C, Duchesne G, Kovacev O, D'Este C; Trans-Tasman Radiation Oncology Group. Denham JW, et al. Among authors: mameghan h. Lancet Oncol. 2005 Nov;6(11):841-50. doi: 10.1016/S1470-2045(05)70348-X. Lancet Oncol. 2005. PMID: 16257791 Clinical Trial.
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: a report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group.
Gogna NK, Matthews JH, Turner SL, Mameghan H, Duchesne GM, Spry N, Berry MP, Keller J, Tripcony L; Trans Tasman Radiation Oncology Group. Gogna NK, et al. Among authors: mameghan h. Radiother Oncol. 2006 Oct;81(1):9-17. doi: 10.1016/j.radonc.2006.09.001. Epub 2006 Sep 28. Radiother Oncol. 2006. PMID: 17011058 Clinical Trial.
Prostate cancer and PSA screening.
Mameghan H. Mameghan H. Aust Fam Physician. 1999 Aug;28(8):777-81. Aust Fam Physician. 1999. PMID: 10495525 Review.
57 results